Tianmin Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Tianmin Zhu has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Fangming Kong
Chemical & Pharmaceutical Development, Wyeth Research, Pearl River, USA
1 shared publication- Haibo Wang
Zhejiang Hisun Pharmaceutical Co., Ltd., 46 Waisha Rd., Taizhou, Zhejiang 318000, PR China
1 shared publication Mahdi Fawzi
Chemical & Pharmaceutical Development, Wyeth Research, Pearl River, USA
1 shared publicationOu Yu
Zhejiang Hisun Pharmaceutical Co., Ltd., 46 Waisha Rd., Taizhou, Zhejiang 318000, PR China
1 shared publicationRushung Tsao
Chemical & Pharmaceutical Development, Wyeth Research, Pearl River, USA
1 shared publication- Shan Zheng
Department of Pediatric Surgery, Children’s Hospital of Fudan University, Shanghai Key Laboratory of Birth Defect, and Key Laboratory of Neonatal Disease, Ministry of Health, Shanghai, P.R. China
1 shared publication
Latest Publications
- 1 March 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (5) , 1175-1178
Synthesis and evaluation of an injectable everolimus prodrug
- 1 March 2017
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 27 (5) , 1175-1178
Synthesis and evaluation of an injectable everolimus prodrug
- Open Access
- 3 August 2011
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 64 (10) , 673-677
Structural characterization of the tobramycin–piperacillin reaction product formed at pH 6.0
Tobramycin is an aminoglycoside antibiotic that loses a significant amount of activity in the presence of Zosyn at pH 6. As part of our investigation into ways to improve the compatibility of tobramycin with Zosyn (which contains piperacillin and tazobactam in an 8:1 ratio buffered at pH 6 by sodium citrate) by lowering the pH, we identified the reaction product of tobramycin and piperacillin at pH 6.0 and the order of the pKa values of tobramycin. The structure of the main reaction product of tobramycin and piperacillin at pH 6.0 was determined by 2D NMR to be the product of 3″-NH2 reacting with the β-lactam of piperacillin. The order of the pKa values of the nitrogens of tobramycin was determined by 1H and 15N NMR titrations to be 6′-NH2>2′-NH2>1-NH2≈3″-NH2>3-NH2. At pH 4.0, the reaction between tobramycin and Zosyn was almost negligible for a period of up to 2 h. The pH can be lowered by adding an acid such as HCl or citric acid to Zosyn to make a pH 4.0 buffer.
- 3 August 2011
- Published by Springer Nature in The Journal of Antibiotics
- Vol. 64 (10) , 673-677
Open AccessStructural characterization of the tobramycin–piperacillin reaction product formed at pH 6.0
Tobramycin is an aminoglycoside antibiotic that loses a significant amount of activity in the presence of Zosyn at pH 6. As part of our investigation into ways to improve the compatibility of tobramycin with Zosyn (which contains piperacillin and tazobactam in an 8:1 ratio buffered at pH 6 by sodium citrate) by lowering the pH, we identified the reaction product of tobramycin and piperacillin at pH 6.0 and the order of the pKa values of tobramycin. The structure of the main reaction product of tobramycin and piperacillin at pH 6.0 was determined by 2D NMR to be the product of 3″-NH2 reacting with the β-lactam of piperacillin. The order of the pKa values of the nitrogens of tobramycin was determined by 1H and 15N NMR titrations to be 6′-NH2>2′-NH2>1-NH2≈3″-NH2>3-NH2. At pH 4.0, the reaction between tobramycin and Zosyn was almost negligible for a period of up to 2 h. The pH can be lowered by adding an acid such as HCl or citric acid to Zosyn to make a pH 4.0 buffer.